Barclays PLC Frequency Therapeutics, Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.88 - $3.85 $1,821 - $3,730	-969 Reduced 8.39%	10,587 $41,000
Q3 2022 Nov 03, 2022	SELL	$1.46 - $2.55 $2,654 - $4,635	-1,818 Reduced 13.59%	11,556 $21,000
Q2 2022 Aug 12, 2022	SELL	$1.03 - $2.03 $5,277 - $10,401	-5,124 Reduced 27.7%	13,374 $20,000
Q1 2022 May 16, 2022	BUY	$1.7 - $5.72 $31,446 - $105,808	18,498 New	18,498 $39,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.